CTCBIO Inc. (KOSDAQ:060590)
South Korea · Delayed Price · Currency is KRW 3,365.00
+85.00 (2.59%)
At close: Aug 11, 2026
CTCBIO Market Cap
CTCBIO has a market cap or net worth of 80.45 billion as of August 12, 2026. Its market cap has decreased by -45.73% in one year.
Market Cap
80.45B
Enterprise Value
104.14B
Revenue
128.76B
Ranking
n/a
PE Ratio
13.08
Stock Price
3,365.00
ChartMarket Cap Chart
Since March 3, 2003, CTCBIO's market cap has increased from 10.66B to 80.45B, an increase of 654.97%. That is a compound annual growth rate of 9.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 80.45B | -27.24% |
| Dec 30, 2025 | 110.58B | -29.39% |
| Dec 30, 2024 | 156.60B | -38.79% |
| Dec 28, 2023 | 255.82B | 69.84% |
| Dec 29, 2022 | 150.63B | -28.80% |
| Dec 30, 2021 | 211.56B | 32.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Choong Ang Vaccine Laboratory | 86.00B |
| SunBio,Inc. | 79.38B |
| EyeGene | 72.41B |
| BIO-FD&C | 71.57B |
| QuadMedicine | 70.61B |
| IMGT Co.,Ltd. | 68.17B |
| PanGen Biotech | 67.44B |
| AriBioLab | 65.13B |